Rosmarinic acid (20283-92-5) displays radical scavenging1, anti-inflammatory2 and amyloid-β aggregation inhibition activities3. Rosmarinic acid has also been shown to act as an agonist at GPR354.
1) Miliauskas et al. (2005), Identification of radical scavenging compounds in Rhaponticum carthamoids by means of LC-DAD-SPE-NMR; J. Nat. Prod., 68 168
2) Sahu et al. (1999), Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b; Biochem. Pharmacol, 57 1439
3) Ono et al. (2012), Phenolic compounds prevented amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding; J. Biol. Chem., 287 14631
4) Deng et al. (2012), Multiple tyrosine metabolites are GPR35 agonists; Sci. Rep., 2 373